We need to talk about the healthcare sector today. After 2024 had already disappointed many companies in the sector due to the "corona effect" and was labeled a "transition year", I had actually called for a major recovery in 2025. What happened instead is of course clear: a complete bleed-out of the industry.

In fact, the situation in the healthcare sector is so bad that no returns at all have been achieved across the board in the last three years, and that is bad.

I had actually chosen the healthcare sector as a second pillar in my portfolio alongside my tech investments, as I have a great passion for the topic of healthcare and also like to spend a lot of time on it. Actually, I also had the impression that the healthcare sector is rather defensive as the demand for healthcare services is continuously increasing when there is an increasing number of sicker people in the world. I have therefore created a diversified portfolio of companies that have a predominance in the treatment of a specific disease: Heart defects, mucoviscidosis, diabetes - you can probably already guess where this is going.

At the moment I have several companies in my portfolio whose performance really resembles a horror movie: $ILM1 (-0,63%) , $AFX (-1,97%) , $UNH (+2,35%) , $NOVO B (-7,11%)

Plus some resurrected zombies like $TMO (+0,08%) , $ABBV (+0,12%) , $EW (+1,97%) , $MEDP (-1,74%) whose performance could be reactivated through life-sustaining measures.

Only $SYK (+1,12%) and $VRTX (+1,23%) are developing in line with expectations overall.

In summary, 40% pain, 40% okay and only 20% yes

However, the poor performance is not at all related to the selection of companies. Other giants such as $MRK (+0,07%) and even the most solid healthcare company in the world $JNJ (+0,45%) are not performing satisfactorily either. Some people here in the comments always act as if Novo Nordisk and UNH were the worst companies in the world and everything was foreseeable - but that's just not the case. In fact, they are only falling so sharply and getting so much media coverage because they have always been regarded as the absolute gems in contrast to solala companies like $PFE (-0,95%) it really wasn't an everyday occurrence for them to halve overnight.

Overall, the healthcare sector, which has been battered for years, is now also considered undervalued. So we can still hope for a recovery. Nevertheless, it is slowly becoming a huge problem for me if I put 1/4 of my capital into assets that are outperforming the savings book and not compensating for inflation. The opportunity costs in particular are astronomical, as I have been 80% right in the tech sector in recent years and 80% wrong in the healthcare sector. I spend more money with my left hand than I earn with my right.

The saying comes to mind: "The tide lifts all boats" which is actually supposed to protect against overconfidence. But isn't it also true that an ebb tide lowers all boats? Perhaps neither the great hit rate in the tech sector nor the subterranean hit chance in the health sector is dependent on my investment decisions, but simply a static anomaly.

What I also want to address specifically is that I find it incredibly annoying that investing in the healthcare sector is such a drama club. I sometimes wonder whether we're doing business here or filming a telenovela. I mean, the whole thing with $HIMS (+10,1%) is a complete kindergarten. Why is it that in the automotive industry, complete strangers manage to merge or form alliances just like that and in the healthcare industry they can't even manage to sell a few medications for 3 months without it degenerating into a mud fight and a war of the roses? My gosh.

But now it's up to you. I would be particularly interested to know how people who have been on the market for more than 10 years see it. Have health values always been such a rollercoaster ride or is the industry better than its reputation?

As already announced in one of my last posts, here is the follow-up purchase of $11B (+1,49%)

We have now reached a relatively good bottom. Should we fall again towards €55, I would consider buying more. In addition to my own analysis (see my profile), the decisive factor for the purchase at this point in time was that 2 insiders have now struck in the sell-off. The two supervisory board members Piotr Wierzbicki and Marcin Kuciapski have generously dipped into their own pockets. Marcin in particular has been buying steadily over the last few years and has now made his biggest purchase to date.

However, I assume that the recovery could continue until the middle of next year. Then I will have to judge whether my assessments were correct.

Further additional purchases in the current market environment include:

$MSFT (+8,16%)

$EW (+1,97%)

$OKTA (+1,29%)

$JEN (-0,8%)

$V (+3,28%)

$VRTX (+1,23%)

A voice against McDonald's $MCD (+1,37%)
(+ my alternatives for you)

I wanted to give a brief assessment of the fast food giant and also present some alternatives. I'm surprised that many private investors have been investing so heavily in the golden M recently. In other words, I'm not really surprised. The share has fallen over the year and when a share falls, it becomes cheaper. Isn't that right?

Well, I don't actually think that McD is cheap enough to see a clear buying opportunity here. The price may be quite fair, but I wouldn't recognize an undervaluation. But first of all, one thing that I think is good: I actually think McD is very good if you want to invest in real estate. At this point I say "Ok, before you go into some weird REIT then take McD all right"

Otherwise, however, I'm too skeptical when it comes to restaurants to get in at a P/E ratio of over 20. I'm not alone in this at the moment and that's exactly why the share price has fallen. The point is simply that gastronomy is cyclical. And, as I never tire of emphasizing, consumers now have increasingly empty pockets, which is considerably dampening their mood and ability to spend. In this respect, many gastronomy stocks such as $MCD (+1,37%) and especially $SBUX (-2,51%) possibly go even further downhill. Those who are keen to get in could therefore wait.

So as not to make this too long, I won't explain again why I have a few doubts about the future growth of Mecces in particular, even without the current sector effect. If you are interested, I will be happy to come back to this elsewhere. Instead, here are 3 alternatives that I currently consider to be better (not investment advice):

1) Coca Cola $KO (+0,13%) - I hope I don't have to explain where I get the connection from. But I actually think it's better at the moment. Of course there is a lot of gastro in the share, but it is not quite as vulnerable. You also get roughly the same amount of dividend for your money and essentially just an even more robust share. When I look at them side by side, they both look very similar, but I can't think of any reasons not to bet on CC, given McDonalds' current not-so-cheap price.

2) Rational AG $RAA (+0%) - is actually the ETF for system catering because it manufactures the appliances for such kitchens. As a result, it is also well diversified and has stronger growth. But it is also valued a little higher. I was also invested there for a long time, but it has exactly the same problem as the restaurant industry itself - it is also quite cyclical.

3) Edwards Lifesciences $EW (+1,97%) - Well, you didn't expect that, did you? But the Edwards share is now hardly valued higher than the McDonalds share and offers a great way to profit from the restaurant to the golden M if you think outside the box. I think the medical technology manufacturer specializing in cardiology is virtually predestined to supply MC customers as patients. So instead of investing in what makes people ill, you could also invest in what makes people well again. Unfortunately, there is no dividend for this.

I had to take this opportunity!

Has anyone looked into $EW (+1,97%) why they have slumped so much ? Could it slowly become interesting again ?

Make a little provision for old age🙌 $EW (+1,97%)

Buy order triggered with jump above the resistances of the last months and at the same time also above the 200SMA. Top company with a quasi-monopoly position which has come under pressure in recent years (price-wise - despite great figures) and is therefore currently relatively cheap to buy.

Dear community,

after I have often thought about whether I would like to present my portfolio or not, I'll give myself a jolt with the new function and introduce myself briefly:

Who am I?

27 years old, AT. I have been working in development in the semiconductor industry for 3 years, before that I studied at university with holiday jobs and a small part-time job of 8 hours a week. I live with my girlfriend, am addicted to sports and have been addicted to investing for 1 year.

Career portfolio

Due to the (extensive) acquaintance with the co-founder of $MIOTA I entered the crypto world in 2018 and invested almost €500 (a lot of money as a student at the time) in Iota and other cryptocurrencies. After everything collapsed there (I had -95% in the meantime), I didn't want to know anything more about investing and concentrated on my studies and my life.

With my master's degree and the start of my permanent employment in 2021, the question then arose as to what I would do with my money and I finally ended up investing via various ideas (Amazon dropshipping, startup, etc.). After about 1 month of reading in, my first position was the $LCUW which I bought at $ASML (+1,3%)
$IFX (+1,28%)
$LIN (-3,6%) and $XMME (+0,65%) expanded it. Over time, more shares were added and by registering on Getquin, the MSCI Word + EM was then shifted to the $VWRL (+1,71%) (thanks to the community :)). Since then, most of the income (savings rate currently 2k/month ~50%) has been invested, $VWRL (+1,71%) and $SPYD (+0,12%) by savings plan + dip purchases, shares always by individual purchases.

Structure

As I come from the technology sector and see where technology is used everywhere, I deliberately have an abundance of technology in my portfolio. Basically, I'm focusing on growth (I'm still young) and core-satellite, with the aim of being able to live well from dividends and withdrawals in my later years and to give my children a good start in life. In addition to the Flatex custody account, there are also a few gambles in the crypto sector, but nothing major. Maybe in 10 years it will help with the house and Lambo

What would I like to change?

Through the community I came across the $SPYD (+0,12%) came to my attention. The good dividends and the good price performance in the past (> $VWRL (+1,71%) ) persuaded me to invest in the ETF as well. In recent weeks, however, I have become increasingly dissatisfied with the ETF's performance, partly because the companies it contains don't quite match my objectives. I will now (after feedback from the community) build up the $EQQQ (+1,47%) as a satellite ETF via a savings plan. The $SPYD (+0,12%) currently remains in place as I expect a tech correction in the near future where the $SPYD (+0,12%) should serve as a support. Whether I keep the Aristocrat or not is still up in the air (outcome of the post was 60% Nasdaq100, 22% SPYD and 18% both), I would be happy to receive feedback here. Also on the watchlist at the moment are $EW (+1,97%) and $CRWD (+0,42%) which, however, is a competitor to $FTNT (-2,45%) is. However, as I consider the sector to be very important for the future, I will get both on board.

Favorite stocks

$ASML (+1,3%) (The technology is extremely interesting)

$CDNS (+3,62%) (The program is complete garbage but quasi monopoly with $SNPS (+2,7%) )

Hate shares

$SRT3 (-1,7%) (Let's see if this is still something, was a purchase on online Google suggestions)

$NRJ (+1,36%) (I'll hold on to it, maybe it will be something in a few years)

$MIOTA (Well, the share price says it all :D)

I would be happy to receive feedback and suggestions for improvement, please let me know any criticisms/suggestions, that's the only way to keep learning;)

In this sense, enjoy the day and have a nice New Year's Day

Send via Internet-Explorer